Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
Recruiting · NCT05795140 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS | Cytopenia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Urogenital Diseases, anemia, atypical hemolytic-uremic syndrome, blood platelet disease, glomerulonephritis, hematologic disorder, hemolytic anemia, hemolytic-uremic syndrome, immune system disorder, kidney disorder, membranoproliferative glomerulonephritis, nephritis, thrombocytopenia, thrombotic microangiopathy, uremia, urinary system disorder | Recruiting | Phase 3 | 2026-06-04 | NCT05795140 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||